Latest posts by Lancet Global Health (see all)
- [Articles] Effect of Ebola virus disease on maternal and child health services in Guinea: a… - Feb. 23, 2017
- [Comment] The end of the Ebola virus disease epidemic: has the work just begun? - Feb. 23, 2017
- [Articles] Levels and trends in contraceptive prevalence, unmet need, and demand for family… - Feb. 19, 2017
- [Articles] Community resource centres to improve the health of women and children in informal… - Feb. 19, 2017
David Osrin and Tim Colbourn (November, 2016)1 uphold a recommendation to restrict use of chlorhexidine to “infants born at home in environments with high neonatal mortality rates” and assert that “Cochrane reviews, a meta-analysis, and these two new trials have not supported an effect after hospital births”. We do not think it is clear how one could come to such a conclusion from the evidence in the cited papers.
Read article here: